Engineered Immune Cells Lead to Leukemia Remission

Five patients with relapsed B cell acute lymphoblastic leukemia quickly achieved complete remission after treatment with autologous engineered T cells, according to research published in the March 20 issue of Science Translational Medicine .

http://www.mentalhelp.net/poc/view_doc.php?type=news&id=154017&cn=26